Compare XBIO & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIO | ULY |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.8M |
| IPO Year | N/A | N/A |
| Metric | XBIO | ULY |
|---|---|---|
| Price | $2.13 | $2.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 27.3K | ★ 414.8K |
| Earning Date | 03-17-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,858,935.00 | ★ $127,932,000.00 |
| Revenue This Year | $1.99 | N/A |
| Revenue Next Year | $20.00 | $18.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.30 | N/A |
| 52 Week Low | $1.90 | $1.74 |
| 52 Week High | $13.93 | $17.99 |
| Indicator | XBIO | ULY |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 46.02 |
| Support Level | $2.05 | $1.82 |
| Resistance Level | $2.69 | $2.75 |
| Average True Range (ATR) | 0.13 | 0.38 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 6.76 | 19.64 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.